Session Type
Meeting
Search Results
Abstract Number: 160
SHM Converge 2023
Background: The key goals of HF therapy are to prevent progression of symptoms, improve quality of life, and prolong survival. Studies have attempted to study and improve post hospitalization outcomes among patients with HF. Social determinants of Health include a wide set of factors from daily life which are responsible for health inequity. Burden of […]
Abstract Number: 161
SHM Converge 2023
Background: Chronic diseases, such as heart disease, diabetes, and cancer, are the leading causes of disability and death in New York State (NYS) and throughout the United States. County Health Rankings (CHR) is a program assessing the nation’s health on a county-by-county basis to provide a summary z-score for each county and determine county health […]
Abstract Number: 162
SHM Converge 2023
Background: Lumbar puncture (LP) is commonly needed in hospitalized patients for both diagnostic and therapeutic purposes. Traditional landmark identification by palpation of the lumbar spine and pelvis often has a low success rate. There is strong evidence showing that the use of ultrasound leads to higher success rates, along with other important patient-centered outcomes such […]
Abstract Number: 163
SHM Converge 2023
Background: Epidemiological data across the USA show health disparities in COVID-19 infection, hospitalization, and mortality by race/ethnicity. The state of New Mexico has the largest Hispanic and the third largest American Indian/Alaskan Natives (AI/AN) populations per capita in the United States. Complications from severe COVID-19 and mortality are largely unreported in diverse cohorts of hospitalized […]
Abstract Number: 164
SHM Converge 2023
Background: GLP1RAs have been proven beneficial for weight loss in patients with NAFLD with or without Diabetes. However, such use is limited due to cost and limited insurance coverage in those without diabetes. Methods: Retrospective chart review of patients with NAFLD seen at Multidisciplinary NAFLD clinic in Low SES community. Results: A total of 11 […]
Abstract Number: 165
SHM Converge 2023
Background: Approximately one-third of patients with acute ischemic stroke (AIS) develop hyperglycemia regardless of pre-existing history of diabetes [1]. Hyperglycemia is associated with increased risk of hemorrhagic transformation and can be considered as a predictor of poor functional outcome after intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) [2]. Additionally, risk of death, hemorrhagic complications, and […]
Abstract Number: 166
SHM Converge 2023
Background: As of 2020, COVID-19 is the third leading cause of death after heart disease and cancer. COVID-19 accounted for more than a million hospitalization in the USA since the onset of the pandemic. Our aim is to investigate the impact of racial disparities on the outcome of COVID-19 admissions. Methods: We queried the National […]
Abstract Number: 167
SHM Converge 2023
Background: Thromboembolic events (TE) have been increasingly reported among patients with COVID-19, causing significant morbidity and mortality. Additionally, it has been established that patients with cancer are at an increased risk of venous thrombotic embolism (VTE), with the annual incidence of VTE being nearly five times higher than in the general population (0.5% compared with […]
Abstract Number: 425
SHM Converge 2023
Background: While the Coronavirus Disease 2019 (COVID-19) pandemic has substantially affected health outcomes globally, care strategies have varied in different regions. For example, while US hospitals primarily admitted patients with severe COVID-19, hospitals in Egypt admitted most symptomatic COVID-19-positive individuals per the May 2020 Ministry of Health and Population management protocol. Additionally, the use of […]